Q9EPI1
Gene name |
Xylt1 |
Protein name |
Xylosyltransferase 1 |
Names |
Peptide O-xylosyltransferase 1, Xylosyltransferase I |
Species |
Rattus norvegicus (Rat) |
KEGG Pathway |
|
EC number |
2.4.2.26: Pentosyltransferases |
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q9EPI1
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q9EPI1-F1 | Predicted | AlphaFoldDB |
No variants for Q9EPI1
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| No variants for Q9EPI1 | |||||
No associated diseases with Q9EPI1
1 regional properties for Q9EPI1
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | Xylosyltransferase, C-terminal | 478 - 658 | IPR024448 |
Functions
| Description | ||
|---|---|---|
| EC Number | 2.4.2.26 | Pentosyltransferases |
| Subcellular Localization |
|
|
| PANTHER Family | ||
| PANTHER Subfamily | ||
| PANTHER Protein Class | ||
| PANTHER Pathway Category | No pathway information available | |
4 GO annotations of cellular component
| Name | Definition |
|---|---|
| extracellular space | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
| Golgi apparatus | A membrane-bound cytoplasmic organelle of the endomembrane system that further processes the core oligosaccharides (e.g. N-glycans) added to proteins in the endoplasmic reticulum and packages them into membrane-bound vesicles. The Golgi apparatus operates at the intersection of the secretory, lysosomal, and endocytic pathways. |
| Golgi cis cisterna | The Golgi cisterna closest to the endoplasmic reticulum; the first processing compartment through which proteins pass after export from the ER. |
| Golgi membrane | The lipid bilayer surrounding any of the compartments of the Golgi apparatus. |
2 GO annotations of molecular function
| Name | Definition |
|---|---|
| metal ion binding | Binding to a metal ion. |
| protein xylosyltransferase activity | Catalysis of the transfer of a beta-D-xylosyl residue from UDP-D-xylose to the serine hydroxyl group of an acceptor protein substrate. |
10 GO annotations of biological process
| Name | Definition |
|---|---|
| cellular response to heat | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heat stimulus, a temperature stimulus above the optimal temperature for that organism. |
| chondroitin sulfate biosynthetic process | The chemical reactions and pathways resulting in the formation of chondroitin sulfate, any member of a group of 10-60 kDa glycosaminoglycans, widely distributed in cartilage and other mammalian connective tissues, the repeat units of which consist of beta-(1,4)-linked D-glucuronyl beta-(1,3)-N-acetyl-D-galactosamine sulfate. |
| chondroitin sulfate proteoglycan biosynthetic process | The chemical reactions and pathways resulting in the formation of chondroitin sulfate proteoglycan, any glycoprotein whose glycosaminoglycan units are chondroitin sulfate. Chondroitin sulfates are a group of 10-60 kDa glycosaminoglycans, widely distributed in cartilage and other mammalian connective tissues; the repeat units consist of beta-(1,4)-linked D-glucuronyl beta-(1,3)-N-acetyl-D-galactosamine sulfate. |
| embryonic skeletal system development | The process, occurring during the embryonic phase, whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. |
| glycosaminoglycan biosynthetic process | The chemical reactions and pathways resulting in the formation of glycosaminoglycans, any of a group of polysaccharides that contain amino sugars. |
| heparan sulfate proteoglycan biosynthetic process | The chemical reactions and pathways resulting in the formation of the heparan sulfate proteoglycan, a glycosaminoglycan with repeat unit consisting of alternating alpha-(1->4)-linked hexuronic acid and glucosamine residues; the former are a mixture of sulfated and nonsulfated D-glucuronic acid and L-iduronic acid; the L-iduronic acid is either sulfated or acetylated on its amino group as well as being sulfated on one of its hydroxyl groups; heparan sulfate chains are covalently linked to peptidyl-serine by a glycosidic attachment through the trisaccharide galactosyl-galactosyl-xylosyl to serine residues. |
| negative regulation of axon regeneration | Any process that stops, prevents, or reduces the frequency, rate or extent of axon regeneration. |
| ossification involved in bone maturation | The formation of bone or of a bony substance, or the conversion of fibrous tissue or of cartilage into bone, involved in the progression of the skeleton from its formation to its mature state. |
| proteoglycan biosynthetic process | The chemical reactions and pathways resulting in the formation of proteoglycans, any glycoprotein in which the carbohydrate units are glycosaminoglycans. |
| response to interleukin-1 | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-1 stimulus. |
1 homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| Q7KVA1 | oxt | Xylosyltransferase oxt | Drosophila melanogaster (Fruit fly) | PR |
| 10 | 20 | 30 | 40 | 50 | 60 |
| YFSHRPKEKV | RTDSNNENSV | PKDFENVDNS | NFAPRTQKQK | HQPELAKKPL | SRQKERLQRK |
| 70 | 80 | 90 | 100 | 110 | 120 |
| LGAQDKGQGQ | SVLGKGPKEV | LPPREKAPGN | SSQGKDLSRH | SHSRKSGGGG | SPETKSDQVP |
| 130 | 140 | 150 | 160 | 170 | 180 |
| KCDISGKEAI | SALTRAKSKH | CRQEIAETYC | RHKLGLLMPE | KVARFCPLEG | KANKNVQWDE |
| 190 | 200 | 210 | 220 | 230 | 240 |
| DAVEYMPPNP | VRIAFVLVVH | GRASRQLQRM | FKAIYHKDHF | YYIHVDKRSN | YLHRQVLQFS |
| 250 | 260 | 270 | 280 | 290 | 300 |
| RQYDNVRVTS | WRMATIWGGA | SLLSTYLQSM | RDLLEMTDWP | WDFFINLSAA | DYPIRTNDQL |
| 310 | 320 | 330 | 340 | 350 | 360 |
| VAFLSRYRDM | NFLKSHGRDN | ARFIRKQDLD | RLFLECDTHM | WRLGDRRIPE | GIAVDGGSDW |
| 370 | 380 | 390 | 400 | 410 | 420 |
| FLLNRKFVEY | VAFSTDDLVT | KMKQFYSYTL | LPAESFFHTV | LENSPHCDTM | VDNNLRITNW |
| 430 | 440 | 450 | 460 | 470 | 480 |
| NRKLGCKCQY | KHIVDWCGCS | PNDFKPQDFH | RFQQTARPTF | FARKFEAIVN | QEIIGQLDSY |
| 490 | 500 | 510 | 520 | 530 | 540 |
| LYGNYPAGTP | GLRSYWENVY | DEPDGIQSLS | DVALTMYHSF | IRLGLRRAES | SLHTDGENSC |
| 550 | 560 | 570 | 580 | 590 | 600 |
| RYYPMGHPAS | VHLYFLADRF | QGFLIKHHVT | NLAVSKLETL | ETWMMPKKVF | KVASPPSDFG |
| 610 | 620 | 630 | 640 | 650 | 660 |
| RLQFSEVGTD | WDAKERLFRN | FGGLLGPMDE | PVGMQKWGKG | PNVTVTVIWV | DPVNVIAATY |
| 670 | 680 | 690 | 700 | 710 | 720 |
| DILIESTAEF | THYKPPLNLP | LRPGVWTVKI | LHHWVPVAET | KFLVAPLTFS | NKQPIKPEEA |
| 730 | 740 | 750 | 760 | 770 | 780 |
| LKLHNGPPRS | AYMEQSFQSL | NPVLSLHINP | AQVEQARKNA | AFTGTALEAW | LVGGTWTAMD |
| 790 | 800 | 810 | 820 | ||
| VCATGPTACP | VMQTCSQTAW | SSFSPDPKSE | LGAVKPDGRL | R |